Targeting RET alterations in cancer: Recent progress and future directions

Shabbir, A., Kojadinovic, A., Shafiq, T., & Mundi, P. S. (2023). Targeting RET alterations in cancer: Recent progress and future directions. Critical Reviews in Oncology/Hematology, 181, 103882. https://doi.org/10.1016/j.critrevonc.2022.103882
Authors:
Arafat Shabbir
Arsenije Kojadinovic
Tabinda Shafiq
Prabhjot S Mundi
Affiliated Authors:
Prabhjot S Mundi
Columbia Affiliation:
Subjects:
Thyroid Neoplasms (MeSH)
Lung Neoplasms (MeSH)
Carcinoma, Neuroendocrine (MeSH)
Author Keywords:
drug resistance
lung cancer
oncology
precision
precision cancer medicine
ret
targeted cancer therapy
thyroid cancer
tyrosine kinase inhibitors
elink
Publication Type:
Article
Unique ID:
10.1016/j.critrevonc.2022.103882
PMID:
36481304
DOI:
10.1016/j.critrevonc.2022.103882
Journal:
Critical Reviews in Oncology/Hematology
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record

Record Created: